SuperworthCalidi Biotherapeutics market cap CLDI
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.6M
- Highest close in our data
- $290.8M
- Sep 2022
Calidi Biotherapeutics is worth $1.6M at the close on Oct 23, 2026, at $0.64 a share.
That is down 69% over the last year and down 99% over five years.
Its highest close in our data was $290.8M in Sep 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.6M | $1.6M | $8.5M | −82% |
| 2025 | $8.9M | $4.9M | $24.2M | −49% |
| 2024 | $17.5M | $5.7M | $51.7M | −67% |
| 2023 | $53.5M | $19.3M | $104.1M | −47% |
| 2022 | $100.5M | $98.7M | $290.8M | −64% |
| 2021 | $282M | $282M | $283.2M | n/a |
Against its peers
Companies in Healthcare nearest Calidi Biotherapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CLDICalidi Biotherapeutics | $1.6M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| Peer median | $11.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Calidi Biotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.